vimarsana.com

சஸ்டசுந்தர் முயற்சிகள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kaya Ltd leads gainers in B group

Bal Pharma Ltd, Alpa Laboratories Ltd, Sastasundar Ventures Ltd and Nectar Lifescience Ltd are among the other gainers in the BSE s B group today, 22 April 2021. Bal Pharma Ltd, Alpa Laboratories Ltd, Sastasundar Ventures Ltd and Nectar Lifescience Ltd are among the other gainers in the BSE s B group today, 22 April 2021. Kaya Ltd surged 20.00% to Rs 283.85 at 12:04 IST. The stock was the biggest gainer in the BSE s B group. On the BSE, 39479 shares were traded on the counter so far as against the average daily volumes of 9342 shares in the past one month. Bal Pharma Ltd soared 19.99% to Rs 86.45. The stock was the second biggest gainer in B group. On the BSE, 1.17 lakh shares were traded on the counter so far as against the average daily volumes of 18849 shares in the past one month.

SastaSundar Ventures: Is This Listed E-commerce Company Really Undervalued?

 0 SastaSundar Ventures Ltd (SVL) is a listed online pharmacy and healthcare services-provider that is remarkably undervalued compared to its private equity funded unlisted competitors like pharmeasy.in, netmeds.com and 1mg.com. It sells its products through sastasundar.com and its own mobile application. SVL also sells private labelled healthcare, consumer and personal-care products through. Premium Content

Digital Healthcare Platform SastaSundar is Extending its Wings to Cover the Realm of Preventive Wellness, in Association with Japanese Sportswear MNC Asics

SastaSundar e-pharmacy to expand market presence - The Hindu BusinessLine

December 21, 2020 Kolkata-based e-pharmacy, SastaSundar, plans to expand into the northern and western regions while strengthening its presence in the existing markets in the eastern and north-eastern regions. According to BL Mittal, Founder and Executive Chairman, SastaSundar.com, there has been a steady traction in demand from the smaller towns and cities, as getting access to certain medicines has been difficult in some of these places. “We are currently present in around nine States. We are looking to move into Maharashtra, Gujarat, Delhi, UP, Rajasthan, Haryana and Odisha in the next one-to-two years thereby taking our total network to around 16 states,” Mittal told

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.